Medicine and Dentistry
ALK Inhibitor
50%
Biopsy Technique
30%
Droplet Digital Polymerase Chain Reaction
28%
Epidermal Growth Factor Receptor
50%
Formaldehyde
50%
Fusion Gene
50%
Gene Frequency
8%
Leukocyte
16%
Lung Cancer
100%
Neoplasm
30%
Non Small Cell Lung Cancer
36%
Progression Free Survival
16%
Protein Tyrosine Kinase
10%
Resistance Mutation
58%
Survival Time
8%
Tyrosine-Kinase Inhibitor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Anaplastic Lymphoma Kinase Inhibitor
50%
Epidermal Growth Factor Receptor
50%
Formaldehyde
50%
Lung Cancer
100%
Neoplasm
30%
Non Small Cell Lung Cancer
36%
Progression Free Survival
16%
Protein Tyrosine Kinase
10%
Protein Tyrosine Kinase Inhibitor
50%
Survival Time
8%
Biochemistry, Genetics and Molecular Biology
Droplet Digital Polymerase Chain Reaction
60%
Epidermal Growth Factor Receptor
50%
Fusion Gene
50%
Gene Frequency
10%
Leukocyte
20%
Progression Free Survival
20%
Receptor Tyrosine Kinase
25%
Survival Time
10%
Tyrosine Kinase
25%
Tyrosine Kinase Inhibitor
50%
